These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19366125)

  • 21. [Research progress on relationship between subchondral bone and cartilage degeneration in osteoarthritis].
    Li Q; Zhang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Feb; 23(2):245-8. PubMed ID: 19275114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteases: a role in overuse tendinopathies.
    Magra M; Maffulli N
    Br J Sports Med; 2005 Nov; 39(11):789-91. PubMed ID: 16244185
    [No Abstract]   [Full Text] [Related]  

  • 23. Neural stem cells at the crossroads: MMPs may tell the way.
    Tonti GA; Mannello F; Cacci E; Biagioni S
    Int J Dev Biol; 2009; 53(1):1-17. PubMed ID: 19123122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel methods for tendon investigations.
    Kjaer M; Langberg H; Bojsen-Møller J; Koskinen SO; Mackey A; Heinemeier K; Holm L; Skovgaard D; Døssing S; Hansen M; Hansen P; Haraldsson B; Carøe I; Magnusson SP
    Disabil Rehabil; 2008; 30(20-22):1514-22. PubMed ID: 19005915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanical regulation of matrix metalloproteinases.
    Blain EJ
    Front Biosci; 2007 Jan; 12():507-27. PubMed ID: 17127313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invited commentary.
    Doenst T
    Ann Thorac Surg; 2008 Oct; 86(4):1249. PubMed ID: 18805170
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunohistochemistry of MMPs and TIMPs.
    Okada Y
    Methods Mol Biol; 2001; 151():359-65. PubMed ID: 11217311
    [No Abstract]   [Full Text] [Related]  

  • 28. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.
    Grässel S; Opolka A; Anders S; Straub RH; Grifka J; Luger TA; Böhm M
    Arthritis Rheum; 2009 Oct; 60(10):3017-27. PubMed ID: 19790046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs genetic polymorphisms and plasma levels in hypertensive disorders of pregnancy.
    Luizon MR; Amaral LM; Palei AC
    J Hum Hypertens; 2013 Apr; 27(4):278-9. PubMed ID: 22971750
    [No Abstract]   [Full Text] [Related]  

  • 30. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases.
    Cawston T
    Mol Med Today; 1998 Mar; 4(3):130-7. PubMed ID: 9575496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Otago Glaucoma Surgery Outcome Study: the pattern of expression of MMPs and TIMPs in bleb capsules surrounding Molteno implants.
    McCluskey P; Molteno A; Wakefield D; Di Girolamo N
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2161-4. PubMed ID: 19117928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification of MMPs and TIMPs.
    Shimokawa K; Nagase H
    Methods Mol Biol; 2001; 151():275-304. PubMed ID: 11217306
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of biochemical markers of bone and cartilage metabolism to monitor osteoarthritis--dreams and reality.
    Roughley PJ; El-Maadawy S
    J Rheumatol; 2003 May; 30(5):910-2. PubMed ID: 12734881
    [No Abstract]   [Full Text] [Related]  

  • 35. What are the roles of metalloproteinases in cartilage and bone damage?
    Murphy G; Lee MH
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv44-7. PubMed ID: 16239386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finding the culprit: a review of the influences of proteases on the chronic wound environment.
    Rayment EA; Upton Z
    Int J Low Extrem Wounds; 2009 Mar; 8(1):19-27. PubMed ID: 19164416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The unifying role of matrix metalloproteinases in atheroma and vascular stroke.
    Tayebjee MH; Lip GY; MacFadyen RJ
    Stroke; 2004 Oct; 35(10):2239. PubMed ID: 15308790
    [No Abstract]   [Full Text] [Related]  

  • 39. Osteoarthritis: linking nitric oxide and metalloproteinases in canine articular ligament pathology.
    Rajamäki MM; Sorsa T
    Vet J; 2006 Nov; 172(3):400-1. PubMed ID: 16314129
    [No Abstract]   [Full Text] [Related]  

  • 40. PICSO in progress: lactate, oxygen, eNOS, iNOS, MMP and TIMP in the PICSO treated myocardium--a preview.
    Lechner J; Grünbichler H; Schrutka I; Waldthaler A; Franz C; Mohl W
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):29. PubMed ID: 19618598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.